搜索
Tvardi Therapeutics Ord Shs
TVRD添加自选
1.320USD
-0.250-15.92%
收盘 09-23 16:00（美东）
16.49M总市值
0.20市盈率 TTM
关于 公司
Tvardi Therapeutics Ord Shs 简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Tvardi Therapeutics Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace L. Hall, Jr.
Mr. Wallace L. Hall, Jr.
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
Mr. Dan Conn, J.D.
Mr. Dan Conn, J.D.
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. John Kauh, M.D.
Dr. John Kauh, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace L. Hall, Jr.
Mr. Wallace L. Hall, Jr.
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
常见问题
Tvardi Therapeutics Ord Shs的前五大股东是谁？
Tvardi Therapeutics Ord Shs 的前五大股东如下：Dr. Susan Shiff, Ph.D.
哪个业务部门对Tvardi Therapeutics Ord Shs的收入贡献最大？
在2026Q4，Other revenue 业务部门对Tvardi Therapeutics Ord Shs的收入贡献最大，创收1.32M，占总收入的51.50%。